MedRx Co., Ltd announced a private placement of 55,800 28th stock acquisition rights at a price of ¥22 per warrant for the gross proceeds of ¥1,227,600 and 40,000 29th stock acquisition rights at a price of ¥17 per warrant for the gross proceeds of ¥680,000 for the total gross proceeds of ¥1,907,600 on January 11, 2024. The transaction will include participation from returning investor, Evo Fund, a fund managed by, Evolution Capital Management LLC. The transaction has been approved by the shareholders of the company an dis expected to close on February 5, 2024.

The warrants will be exercisable into shares of the company at an exercise price of ¥93 per share.